[Federal Register Volume 60, Number 32 (Thursday, February 16, 1995)]
[Notices]
[Pages 9048-9049]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-3819]
=======================================================================
-----------------------------------------------------------------------
UNITED STATES INTERNATIONAL TRADE COMMISSION
[Investigation No. 337-TA-349]
Commission Decision To Extend by Ten Days the Deadline for
Determining Whether To Review an Initial Determination
AGENCY: International Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
In the Matter of: Certain Diltiazem Hydrochloride and Diltiazem
Preparations.
SUMMARY: Notice is hereby given that the Commission has extended by ten
days, i.e., from March 20, 1995, to March 30, 1995, the deadline by
which it must determine whether to review the presiding administrative
law judge's final initial determination (ID) in the above-captioned
investigation.
[[Page 9049]] FOR FURTHER INFORMATION CONTACT: Cynthia P. Johnson,
Esq., Office of the General Counsel, U.S. International Trade
Commission, 500 E Street, SW., Washington, DC 20436, telephone 202-205-
3098.
SUPPLEMENTARY INFORMATION: On February 2, 1994, the presiding
administrative law judge (ALJ) issued his final ID in this
investigation. The ALJ determined that no violation of section 337 of
the Tariff Act of 1930, as amended, has occurred in the importation or
sale of certain diltiazem hydrochloride and diltiazem preparations by
reason of infringement of claim 1 of U.S. Letters Patent 4,438,035.
Under Commission interim rule 210.53(h), the ID would have become the
determination of the Commission on March 20, 1995, unless review was
ordered or the review deadline extended.
On February 6, 1995, complainants Tanabe Seiyaku Co., Ltd. and
Marion Merrell Dow, Inc. filed a letter requesting a six-day extension
of time--from February 15, 1995, until February 21, 1995--to file a
petition for review of the ID. On February 7, respondents Mylan
Pharmaceuticals, Inc., Mylan Laboratories, Inc., and Profarmaco Nobel
LRL submitted a letter taking no position on complainants' request for
an extension of time, but requesting, in the event the Commission
grants complainants' request, a six-day extension of time--from
February 28, 1995 to March 6, 1995--to file their response to
complainants' petition for review. A similar request was made on
February 8, 1995, by the Fermion respondents.
This action is taken under the authority of section 337 of the
Tariff Act of 1930 (19 U.S.C. 1337) and Commission interim rule
210.53(h) (19 CFR 210.53(h)).
Copies of the nonconfidential version of the ID and all other
nonconfidential documents filed in connection with this investigation
are or will be available for inspection during official business hours
(8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S.
International Trade Commission, 500 E Street SW., Washington, DC 20436,
telephone 202-205-2000. Hearing-impaired persons are advised that
information on this matter can be obtained by contacting the
Commission's TDD terminal on 202-205-1810.
Issued: February 10, 1995.
By order of the Commission.
Donna R. Koehnke,
Secretary.
[FR Doc. 95-3819 Filed 2-15-95; 8:45 am]
BILLING CODE 7020-02-P
